<DOC>
	<DOC>NCT02695758</DOC>
	<brief_summary>A non-blinded randomized controlled trial, in which participants undergoing primary reverse or total shoulder arthroplasty are randomly assigned to one of two treatment groups.</brief_summary>
	<brief_title>Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>1. All individuals undergoing primary reverse and total shoulder arthroplasty by the shoulder service at Methodist Hospital or Rothman Specialty Hospital. 1. Psychiatric illness as defined by comorbid diagnosis of bipolar disorder or schizophrenia 2. Revision arthroplasty, arthroplasty for fracture 3. Unable/unwilling to consent for enrollment 4. Unable to complete postoperative pain survey 5. Known adverse drug reaction or allergy to the medications used 6. Chronic pain syndromes (including reflex sympathetic dystrophy, fibromyalgia, chronic diffuse musculoskeletal pain) 7. Patients taking long acting narcotic pain medications (including extended release narcotic pain medications and methadone). 8. Patients under the age of 18 years 9. Patients with history of hepatic disease 10. Pregnant women or women who are breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>